StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · SNYR·Healthcare

Synergy CHC Corp. Stock Analysis & AI Score

Synergy CHC Corp. (SNYR) has an ST Score of 46.6 (C+), driven by its Forecast (A) and held back by its Momentum (D-). Analysts rate it Buy with a $7.50 price target (+8187.3% upside).

Market Closed
$0.09
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
47
ST Score
46.6/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Distribution
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

SNYR
46.6out of 100
Grade C+

Synergy CHC Corp. (SNYR) has an ST Score of 46.6 (C+), driven by its Forecast (A) and held back by its Momentum (D-). Analysts rate it Buy with a $7.50 price target (+8187.3% upside).

Strongest
ForecastA
Weakest
MomentumD-
All factor grades
  • ForecastA
  • ValuationB
  • Financial StrengthB-
  • ProfitabilityC+
  • GrowthC+
  • MomentumD-
  • Piotroski1/9
Score methodology
Press Releases

Contact

SNYR stock: frequently asked questions

What is SNYR's ST Score?

Synergy CHC Corp. (SNYR) has an ST Score of 46.6 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is SNYR a buy, hold, or sell?

Analysts rate SNYR a Buy, with a price target of $7.50 (+8187.3% vs the current price). Our ST Score grades it C+ (46.6/100). The ST Score is a data-driven signal, not a recommendation.

What are SNYR's factor grades?

Valuation B, Profitability C+, Financial Strength B-, Momentum D-, Growth C+, Forecast A.

What is SNYR's valuation grade?

Synergy CHC Corp. (SNYR) earns a valuation grade of B, measured against Medical - Distribution peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is SNYR's growth grade?

Synergy CHC Corp. (SNYR) earns a growth grade of C+, measured against Medical - Distribution peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is SNYR's profitability grade?

Synergy CHC Corp. (SNYR) earns a profitability grade of C+, measured against Medical - Distribution peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is SNYR's financial strength grade?

Synergy CHC Corp. (SNYR) earns a financial strength grade of B-, measured against Medical - Distribution peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for SNYR?

The average analyst price target for Synergy CHC Corp. (SNYR) is $7.50 from 2 analysts, which is +8187.3% versus the recent price of $0.09.

What is SNYR's Piotroski score?

Synergy CHC Corp. (SNYR) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.